>stigmatellin_1
TKVRVLDVGCGGGLLAEEFSKKGWKVTGVDQSAPSIELAKAHSAKVGLNIDYHVSKAQKLPFEDETFDIVYC
>daunorubicin_1
VTGERVLDIGCGRGACLFPAAEKVGSQGCVHGIDIAPGMIEEARKEATERGLRNISLMVMDAETPGFPARSFDLVM
>quinomycin_1
ISGAVLDAGCGTGEDILHLASKGYTVTGLDLSSEAVAIARGKAEERGLDATFAVANALELVGYDGRFDTVV
>ristomycin_1
LLEHIDVKSSRHLLDVGGGDGTTAAALLKANPGLKATLLDLASSVALAEQRVPAEVTDRLTLHPADLLTDPFPSGTDHALFSHVLDTFTAEQCVMLLAKAYEVLPSGGKIS
>prodigiosin_4_1
AYSRFMDIGSGVGSLPVAVAEACPHLEIAICELPKAACYVRDKIMSGEFADRIDVVEGDVIAGTIPQQEYDLIHLGWMLHDYAPDTQLQILR
>distamycin_1
TQRLVDICQAAPGSVVVDVGCGSGLATRLLLERFAHVGSIVGVDPSEHELAIARKRLRDPKVRFLTGRAQDVESLVDPVDVAVLSNVMHQIPESERGSVVNGCYRMLKPGG
>paenilamicin_1
TKESKVLEVGCGHGLLLFHLAPDVKEYVATDLSGTIIERNRERARREGLSHVKLRQAAASEIGGIGESDFDVIVMSSVVHYFPNTLYLEEVIRSAIGLLKEEGILYL
>paenilamicin_2
TKESKVLEVGCGHGLLLFHLAPDVKEYVATDLSGTIIERNRERARREGLSHVKLRQAAASEIGGIGESDFDVIVMSSVVHYFPNTLYLEEVIRSAIGLLKEEGILYL
>pyrrolomycin_3_1
IKGEVLDAGCGNGEISLFLAAEGHHVTGIDIAEGAIARRTAGGGAEALATFAV
>pyrrolomycin_3_2
VKGEVLDAGSGPGWVSLFIASQGHAVTGIDLSADAVEAANAKAADSGVNATFAVGDLLDLSEYRGRFDTVV
>althiomycin_1
QHFQLTGIDVDAQSLDFARRNAQERRLEAHCQFLQRDAWHLDIQDTFDAISSNG
>pristinamycin_1
RRVLEIGCGTGLILSQVAPHTEEYRGTDLSRSVVARLAAHLAGRPDLADKVTVDARAAHETDDLPKGRFDTIVLNSVAQYFPDARYLAGILHRAAELLAPGGTIFLGDI
>pristinamycin_2
LVEHARPQPGQRLLDVGCGLGATLLPAADRIGPTGHALGIDIAEAMIEQAGQEARRQGIDNVELRVMDGEHPDLPARSFDLVL
>puromycin_1
REWTLHRGVFPGTLTAATEVMASIVPYPKGGSFLEVGCGTGVISVTAALHGSDVTALDINEKAVANTLANAERHGVEDRVRVLHSDLYAALEPTDRFDAIFWNVPWTYVEDGFPLSSDLHSAVFDPGYQGQSRFISGARDHLADGGRLLIGTADLGDRERIDAFAAEAGMTVEMLRRVRRIEVVR
>borregomycin_1
GRRALDLGCGGGRNSVLLAEKYDEVLGVDISQRMLDIAAGTHARPNVRYERRGLSDLAPDTDGVFDVVLAVNALFHMGPAERTLPRVRDLIAPGGKLVVV
>chondramide_1
KDVLEIGTGTGLLLARIAPRVRAYLATDFSLEAIRYLETCKARAPELSNVTLLQRMADDFTGFSAGQFDTIVLNSVVQYFPTLDYLSAVIEGALRVLKPGGTLFLGDIRNLALLDAFHASV
>anabaenopeptin_2_1
PKRVWEIGCGTGMLLFKIAPHCQTFIGTDFSTKALQYVQENLTSQNLEKKVKLKQSPANQFEGITPQSYDLVILNS
>staurosporine_3_1
AMDRLTDVFIERLKVGASNHVLDLGCGVGGPGLRVVAQTGARVTGISISEEQVKSANRLAAEAGVADRAVFQHGDAMRLPFPDHSFDAVMA
>isorenieratene_1
LRVLDLGCGTGASTAALLAAAPLARITGVDASAGMLARATAKSWPQGVDFAHHPVEELAGRLEAGSFDAVFAGYLFRNLAD
>tubulysin_1
ELVPRRVLELGCGSGLLLRRLAPRCESYWGTELSPVAVERLREQLQTGGSPLAQRVRLMAQPADDFSGLPEAGFDTVILNSVTQLFPSVDYLLRVVEGALRVLQPGGTLFIGDVQNLR
>rhizopodins_1
RDVLEIGCGKGLLLWRLVPRCQSYFATDFSANAVAHVRGHLHQLGGDAGKVTLQVAPADDLRALAHRRFDTIILNSVVQYFPTSEYLLRVLEAALGLLTPDGRVLI
>hassallidins_1
QALKPQRVLEIGCGTGMILLNIADQVESYWGTDFSQAAIIRLTNILQNRSWNHINLLTREATDFSEIPENYFDSIVINSVAQYFPSIEYLQQVITGALRILAPGGSLFIGDNRNLSLLNYFHASVA
>bryostatin_1
EGSFTQPNAKVCEKMLAWAVNNSKNNHGDLLELYCGNGNFTLPLSQNFNRVIATEVSKSSVHSAQKNIKKNNIDNVSILR
>calcimycin_1
EWTLLPDVFAPFHSPSTANYSQWLPYPAGGTLLEMGCGAGVTAVYAALSGCAGVTAVDIVPAAVDNTRRNAERHGVADRVRVLESDMFGALGTGERFDLVFWNSNAIEAPADFVYTKDLEHSVLDRGYQSHRAYLREGPRHLTDDGRLFIGFNSR
>rapamycin_1
VLMRLLEGGRIENVLELCGGTGFASRMLAERHSKVQATSIDLSPELTAVGPHKLASRGIDNVTLVEGDVSTLPYPDDSFDTVMSAFGLHEVPTAGRLSAIRESVRVLKPGGRFVIVD
>rapamycin_2
CDGRTVLEVGCGMGEGLNFLSRLVPTARMTGLDLAPKAIASATATLSRGDTLRFVQGDAEELPFEDSSVDVLVNIESSHTYPNLGRFLREAARALRRGGALSHI
>myxoprincomide_1
LSFQPKRVLELGCGTGLLLYRLAPRCEAYWGVDFARPALDRIERQRERMGGALDSVHLLHQSVDDFSALEPGSFDTVVINSVVQYFSSPEFLLDVLRGAVRVLKPGGRVFLGDVRSLELLEAFR
>physostigmine_1
GWSVLDAGCGTGHTLIGLARAYPHVHFVGLEPSDASRDIARHLAERHGTTNVEIVDGAIPDTVIERRFEFIYS
>leupyrrin_1
KGKHVLEVGSGRGGGSNYVAEYLEPASVTGLDLSSAAIDFCRRAHTADRLTFVEGTAMDLPFKDSSFDIVMNVESSHCYPSFDKFLSEAARVLRPGGLFSWVDARFDDRLLDLERSF
>quinocarcin_1
LPGRALDLGCGNGRNALYLARHGWQVSGVELVGHAVKEARRKMAAAGADVRVVHGDASRLSDYDMGDGFDLVVDSCCYHAVA
>nemadectin_1
TDHMIGKLREHTGRPVRRVLDVGCGSGRPALRLAHSEPVDIVGITISPRQVELATALAERSGLANRVRFECADAMDLPFPDASFDAVW
>K_252a_2_1
LVELLGIEKGQQILDVGCGRGAVTFPLAEAVGPTGRVFGIDLSAGMVEALRASVAAAGVPNIEVRHMDGQRPGFEPREFDAI
>cystobactamide_1
LLLAELADRQANQPLKVLDVAAGHGLFGLAIAQRNPKAHVTFLDWENVLQVARENATKAGVLDRVEFRPGDAFSVDFGKELDVILLTNFLHHFDEAGCEKILKKAHAALKEGGRVLT
>chartreusin_2_1
APQPGERVLDVGCGRGAALFPAARAVGPTGRAVGIDIADTMIEAARAEAARAGAENVELLVMDAERPSFARHSFE
>argimycin_1
GGECLLDIGCGWGSLTLFMAQEYGCEVTAVTPSAPQAEYVREQAARAGLSGRVILRIGSYSDMEVEGRYDAATM
>sibiromycin_1
RVHRVLDVGGGDAVNAVALARAHPSLRVTVLDRPGALEVARKTIAEAGLEERVRTHAADIFTDSYPAGHDCVLFAHQLVIWSPEQNLTLLRKAYDAVEPGGRVLVFNAFTDDDRTGPLY
>sibiromycin_2
RTWTQLSGVVGGEYNYATGLFASSLPYDGVHSMLEMGCGCGVAAVLGALAGVPRVTALDINPAAVRTAQLNAERHGVADRVTALVSDLFSAVPEDTAYDLIFWNSPFIQVPADHALDSDLAYHFFDPGYTMHERFLREARRRLTPAGRLFLG
>retimycin_1
RRVLELGAGSGLMLAHLAGRAESYWATDFAESAIERLRHQTQHEGLSDVELRCQAADDFTGLPRGEFDTVLLNSVVQYFPNEHYLEQVLDGAWELLAPEGRLILGDIRRLDSLPVLQGAI
>erythromycin_1
EANQELANQLAEAAGISEGDEVLDVGFGLGAQDFFWLETRKPARIVGVDLTPSHVRIASERAERENVQDRLQFKEGSATDLPFGAETFDRVTSLESALHYEPRTDFFKGAFEVLKPGGVLAI
>meilingmycin_1
RLTDHLIGKLGDIAGRRVLDVGCGSGRPTVRLAQRAPTEVVGVTVSPVQIERATALAEREGVADRVRFIRADAMALPFPDASFDAVW
>liposidomycin_1
MLADVYPTRSGKLLDIGCGTGTYSLLFAELGFEVHGVDTSEGMIARAREKALSRSGPGGPPAVMFSVLDAQHISGRYDAVFS
>saframycin_a_1
RSVLDVGCGTGKLLEEAGRRWPQARLYGVDPADRMVEIARGRLPGAELT
>saframycin_a_2
ANQHLVEVLDLSGTSKLLDCGGGDAVNSIALAQANPHIEAGILEIPPTAPLTEKKIAEAGLSDRITVKPGDMHTDEFPTGYDTVMFAHQLVIWTPEENTALLRKAYNALPEGGRVIIFNS
>pyrrolomycin_1
ISGEVLDAGFGPAGLSLYLATEGYAVTGIDQSPEAVDAARARARQRGLRASFAVGDLLDLSEYRGRFGTVV
>staurosporine_2_1
AMDRFTDVCAERMRVDTLSHVLDLGCGVGGPALRIVSRTGARVTGVSVSEEQIRTAGRLAAEAGLADRAAFRHGDAMRLPFADASFDAVL
>staurosporine_2_2
PDVPVAEATDRLTDLVAERLALRPGRHLLDVGCGIGVPALRIAGAHGVRVTGVTVSTQQVAEATRRADRSGVRDQVSFRFADAMSLP
>melithiazol_1
ILYRGVDFSTRTRVLDIGCGHAADLVDLARAHPHLELHGCNISPDQIEVGRQRIRALGLDGRVLLHYQDSSRDQFPSTYDLVIAYQVIHHIRAKSDLFANISRSMKPGGLLIM
>elansolid_1
LPKNGVVADVGGGPGVYSAWMAKAGYEVYLFDPVPKHIEQATKKAAKYKKNPFKAILGEARKLDLADASADVVILHGPLYHLQEKKDRIAALREAYRVLKPGGVLL
>curacin_3_1
DFSSTKKVLDFGCGYGSDLITLAKNHPHLQLNGYTISSGQAKFAANQVNDYQLQEQIQIFNRDSSKDEFPDNYNLAFGFEVAHHIKDKSLLFSNISRHLQEEGLL
>curacin_2_1
DFSSTKKVLDFGCGYGSDLITLAKNHPHLQLNGYTISSGQAKFAANQVNDYQLQEQIQIFNRDSSKDEFPDNYNLAFGFEVAHHIKDKSLLFSNISRHLQEEGLL
>aclacinomycin_2_1
PAAGARVLDVGCGRGACVFPAAERVGPEGRVVGIDVAEAMIEEATKEAALRDAAMVELRVMDGEHPDFAPHSFDVVL
>diaphorin_1
GSDKLSRIMINKTSITKGQRFIDIGCGFGLSGIRLAKAKGCRVDGITISKFQQESAMKTAKAEGLLDKVNFLHGDALNLPFDNDSFD
>skyllamycin_1
PASVLDIGCGTGLYSQLLLERFPKWRATGLEAPHIAPIAEAQAQRLGVADRFDVQVRDFWTESWGSDHDLLIFVNIFHLQTPESSLELLRKSKESLADGGLICIADHMVTDEQE
>indolmycin_1
IVNLLESLRPEGRICDIGCGTGARLLRVCRRVNQPGIGYDLSAKAVEAARETVDEARRIGVDIDVRQGDATALTQ
>carotenoid_16_1
LRVLDLGCGTGASTAALLAAAPLARITGVDASAGMLARATAKSWPQGVDFAHHPVEELAGRLEAGSFDAVFAGYLFRNLAD
>toxoflavin_1
SGKSVLDLACGFGFFGREIYRRGAAKVVGVDISEKMIELAREESRKYGDPLEFHVRDVANMEPLGQFDLVNAAWLFNYADSVENLRKMFKVVRASLKPDGKLVA
>safracin_1
QDLVKHLDLSRVKKLLDAGGGDAVNAIALAKHNEQLNVTVLDIDNSIPVTQGKINDSGLSHRVKAQALDILHQSFPEGYDCILFAHQLVIWTLEENTHMLRKAYDALPEGGRVVIFNS
>maduropeptin_1
VRHVLDLGGGDGTNSLHLARRRPGLEATVFDQESVVRLAADRIEDPDLRKRVHFHAGDLFADPFPDGCDAILYFHIFEIWSLERNTELLRKCHAALPEGGVCVVY
>microcystin_3_1
ISKAVELLLSNYSPSEPLRILEIGAGTGATTHQVLNACKSDQINYTFTDVSPFFLETARENFTQFPNINYQVLDIEKDPKSQGFSLNSYDLIIAANVLHSTRDLQAETLPHIQSLLRPGGQLLLLELTH
>microcystin_3_2
RPQRVLEIGCGTGLILFQVAPHCDRYWGTDISVVGLDLIRHHLGESKLDLAEQVNLLQRPADDFEGLEAEAFDTIILNSVVQYFPHIDYLVKVLEKAIAAIAPGGRIFLGDVRNLKL
>chivosazol_1
ETLDAACEAMAKLVAETARVSRGDRVLDVGFGFGDQDMYWMKHFEPRQIVGLNVTEMQVDIARRRVAERGLSDRIDLRVGSATEIGFEPASFDKVLAVECAFHFQTRERFLEEAFRVLRPGGRIAM
>rubradirin_1
FRGRVLDVGCGTGEVALMAAALGLPTVGIDPASTAIEIARRKAEERGLQARFLVGDALELGAMGEQFDTVL
>rubradirin_2
FRGRVLDVGCGTGEVALMAAALGLPTVGIDSASTAIGIARRKAEERGLPARFLVGDALNSADLGEQFDTVLDCALFHAFS
>quinolobactin_1
LRILDVACGNGIYGFTFAQQYPQAQVTGLDWPSVASVTEGFARQFGVAERARVIGGDIFSVQIPGQYELVIMSQILHHFDPERCRQLIARARGVLAPGGKLLI
>quinolobactin_2
LLQMLPEVQHAERVLDLGGGPGLVAQALAQRYPGLHATVFDWPPTAAVAGQLAAEAGLQERVAIIGGDLAKDGFGEGYDVIWCSSVLH
>cinerubin_1
LVEHAAPGPGERVLDVGCGRGACAFPAAARVGPKGRVVGIDVAEAMIEEATREAAARGAGAVEFRVMDGEHPDFAHGSFDVVL
>microcystin_1
TVELLLSNYSPLEPIRILEIGAGTGATTHQILQACASRQINYTFTDISPFFLETAKDTFAHSFIEYKVLDIEKDPEIQGFLPGSYDLIIAANVLHSTRDLQGETLPHIRGLLRPGGHLLLLELT
>microcystin_2
LAQQPNRVLEIGCGTGLILFQIAPYCRHYWGTDISSRGLDYIQQHLSKPESQLHHVNLSQRPADNFEGLEAQGFDTIILNSVVQYFPHIDYLLRVLEGAVNTVAPGGCIFLGDVRNL
>albicidin_1
LPADRPIRVLDVAAGHGLFGIAFAQRFRQAEVSFLDWDNVLDVARENAQAAKVAERARFLPGNAFDLDYGSGYDVILLTNFLHHFDEVDGERILAKTRDALNDDGMVITFEFI
>GE2270_1
LALVHRMVTHRGGHTLDLCAGPGVQALTASLRSDRVTAVEINPVAAALCRTNIAMNGLGDRMEVRLGDLYGAVPGEVFDDIVSNPPLLPVPEDVQFAFVGDGGRDGFDISWTILDGLPEHLSDRGACRIVG
>GE2270_2
ALDWSRSRHVVDVGGGNGTLLSCLLAAHPHLRGTVVDRPTSAKAAGAVLASAGVADRGEFRAGDFFEPLPVHGADTYLLSSILHDWDDAAATAILRRCAEAAAPGGRVL
>microsclerodermins_2_1
GRVLEVGCGTGMILLRVAPRVQRYVGVDFSAVVLEQLAAKVAKSGAANVRLARCAATELASLDERAFDAVVLNSVIQYFPSLDYLSRVLEQALASLDDGGAIYL
>mitomycin_1
ATDRLTDMMAERLRIGAGSRVLDLGCGVGTPGVRIARLSGAHVTGISVSHEQVVRANALAEEAGLADRARFQRADAMDLPFEDESFDAVIALESIIHMPDRAQVLAQVGRVLRPGGRLV
>ajudazol_1
MTHALDVGCGYSSDLLRLATENPHLKVHGYNISPDQIEIGRARAAAAGVGDRMTLFHRDSSRDELPGHYDLIIAFQVIHHIQD
>ajudazol_2
PRRVLEIGSGSGLVLFRIAPSCEQYLGTDFSAAALELLRQRVEKRGLPQVSLHQRSADDFTGVEPQSFDLVILNSVAQYFPSAQYLRTVLEGAVAAVRPGGAVFIGDVRSLPLLEAF
>aeruginosamide_1
QPGNYIFDAGCGAGIPAIHIAQSYPGTRIEGITISEVEAAEAQIRIAQANLVDRVRVQVGDFHAPPFPDEVFDVVFFNDSIKYSNQVSQVLAEAKRVLRPGGTLYI
>cladoniamide_1
QLPKGQRALDIGCGGGNNCVMLAERYDEVVGVDISRRMLDIAAAKPARVPVRYQHRSALDLTPAADGTFDLVMSVNAVFHLGPAPRVLPRLRDLVAPGGRLV
>chelocardin_1
AELMAEQLLPWAKDRDSVDVLDVACSHGYYGVNLAKAEPKARVWGVDWPNVLPITAKNYERNGISDRFEGIPGDMFSVPLGGPYDVVMITNVLHHFSADTSTNLLRRLFDVLKPGGRIAVTGHTFVEG
>herboxidiene_1
TDLVIGGLDAGPGSRVLDLGCGVGGPAVKLASATGAEVVGITVSREQITKATGLARAEGLTGQVVFQYADAMDLPFEEGEFDAVFGLESIMHMDRPAVLAQIAKVLRPGGRL
>tetronasin_1
GLLADTVGMREGDTVLDCGFGYGDQDFYWLKSRKPRQIFGINITPKHVEFASDRARREGVTDRVNFQLASATEIPFPDNTFDRVVSLESAMHYQPRSQFFKEAYRVLKPGGVI
>tetronasin_2
YLDRGLVAPPGRALDLGCGPGRNAVQLAAAGFEVDAIDLSPAAVAWGEERAREAGVDVRFSQGDAFDPDGPGVEGPYDLIHDSGCFH
>rubivivax_gelatnosus_carotenoid_1
TLLSWLPQDLRGRRVLDAGCGTGAASIELARRGAEVVAIDLSPTLVGYARERLPESLGPGSIDFRSGDMLDPALGRFDHVI
>rubivivax_gelatnosus_carotenoid_2
TLLSWLPQDLRGRRVLDAGCGTGAASIELARRGAEVVAIDLSPTLVGYARERLPESLGPGSIDFRSGDMLDPALGRFDHVI
>coumermycin_1
GQTVVDLCCGSGELEIILTSRFPSLNLVGVDLSEDMVRIARDYAAEQGKELEFRHGDAQSPAGMEDLLGKADLVVSRHAFHR
>rebeccamycin_1
ATDRLTDEMIALLDVRSGDRVLDVGCGIGKPAVRLATARDVRVTGISISRPQVNQANARATAAGLANRVTFSYADAMDLPFEDASFDAVWALESLHH
>echosides_1
RVMLDAVEAVVGPEPRILDLACGTGSISDRALRRFPGATSTGVDLDPALLTIARGHFASEPRVEFVTADLRD
>azicemicin_1
SMGAGTTEVAEAVTKHYDFSRFGTVVDVGGGNGTLLAPILAAEPELRGIVFDSEEGVEQAAGVLADAGVADRCEIVAGDFFRAVPRADLYLLKNILHDWDDTRSAAILANCRAAIPEHGRLLLVE
>polyketomycin_1
LQEVFYRNMGDASKKAFAQILDRYDFSGLHHVIDIGGGDGTNSIELARRYPHLEVTVFDQESVTRIAAQRTEDAELSKRVHFHPGDLFTDALPEGADGIMFFHIFEIWSLERNTELLRKCYEALPPGGVCLV
>bryostatin_2_1
EGSFTQPNAKVCEKMLAWAVNNSKNNHGDLLELYCGNGNFTLPLSQNFNRVIATEVSKSSVHSAQKNIQKNNIDNVSILR
>kirromycin_1
ADRTVLEVGCGTGEGLNFLSRLVPGARMTGLDLSPKAVARAEATLARGETLRFVQGDAEKLPFEDSSVDVLINIESSHTYPDLGRFLHEAARVLRPGGTLSHI
>o_methylkolavelool_1
TNLMIEKTPIKPGQHMLDLGCGTGLPAIRMASAKQCHVHGLTVAHGQVAEAQATIQAMQMQELVHINWGNAMELPF
>oxazolomycin_1
KPRRVLEIGCGTGLLLSRVAPHCESYHGTDISSAALDFVRTRLLADRPELANVTLSHRAADRTAGIGDEPYDLVILNSVAQYFPDGAHLRTVLGQAVDSLAGNGAVF
>undecylprodigiosin_1
AIARTLDRNAPVRLLEVGCGSGTYVRYAAELNPRLSALAVDLQQDVADSAAANMAEWGLTDRVETRQADLRTLDAQPQFDLVTLHNNIYYFPEAERVEALRRAHDLLAPGGRLLLT
>isorenieratene_2_1
PRVLDLGCGTGASTAALAAVLPGADITAVDASAGMLRRAAGRPWPRPVRFVHAPVEGLAEAGVRGPFDAVFAAYLLRNTADPDAVLAGAYRMLAPGGRLA
>chrysomycin_1
TVFDDAMTEASRQLIAPVVDAYDFGGTGTLVDVAGGHGALLAAILAAHPGLRGLLYDRPEVVEGAKQTFQDRGVDDRVEIVAGDFFDSVPEGKDAYLLSNVIHDWDDEPSLTILGNCRRALAEGGRVLLVE
>chrysomycin_2
EITGDVLDVGCGLGDNAAFLAGRGHRVTAVDVAEAAVREARRRAEDSGVDVEFAVADATRLTGYDGRFDTVVDSACFHSLSEDERERYLRALRTATRPGGRLH
>AT2433_1
DRLTDQLIARLPVVRDHRVLDVGCGVGKPALRLAGDLGVRVVGVSISEAQIGIANEAARAAGLADRVSFRYADAMRLPFPDASFDGVWAMESLHHMPD
>AT2433_2
LVKELPDPHGRRALDLGCGTGSNAIYLAGLGWDVVGVDTAPNAIAQARRRAKAAGVDPRLLVGDVTE
>mithramycin_1
DLLADTLEPWAAGRERLDVLDVACGHGLYGYTVARRYPQARVRSVDWPGVLEHSRGHAERLGVLDRVELTPGDMFDVPLGGPYDLSLITNVLHHFSAERAGEMLRRLAEATRPGGRIGIVAVT
>arenimycin_1
LIEIAAPRPGERVLDVGCGRGSCLFPARDGVGPTGEVVGIDISAEMVRLTGAEALRRGHTNVTVQVMDGENPRFPRDHFDLVV
>actinomycin_1
ADLTGVRRVLDVGGGDGVNAIALAQANPGVEFTVLDLPGTVEIARKKIAEHGLSDRISVRAADIFADTYPTGHDCVLFANQLVIWSPQENIRLLGKAHAALPDGGRVLVFNA
>actinomycin_2
TGVRRVLDVGGGDGVNAIALARANPGVEFTVLDLPGTVGIARKKIAENGLTDRITVLAADIFTDTYPSGHDCVLFANQLVIWSPEENLTLLRKAHRALPDGGRVLVFNA
>pyralomicin_1
VLDRLRTSPGDHVLDVGCGIGKPALRLAQERKVDVVGVSISEQQIEIAAASARAVPVPTQVSFRTADAMDLPFPDSSFDAVLSLEVLHHVAD
>chromomycin_1
ERDEVKVLDIACGHGLYGYTLAAHDPRARIWSLDWPNVLAVTENNAERLGVRDRAHFIPGDMFEVPLGGPYDVVVVANVLHHFSTERAKRLLARTADAVRPGGQLVAIAIS
>cyclomarin_1
EQVVAAGALRVSDLGAGAGGLLIKLLQEDPARTGTAVDSNGAACAAARQAALAGGVHDRLTVVERPIESLVDDPEPVAGADAILASYVMHDIVADDRIALGVLGALRDALAPGGFLAVA
>spirangien_1
LYHHLATKAPLEGKDVLEVGSGRGGGSWYVARYHRPRRMIGMDLAENAVEFARRAHKAPGLSYQVGDALNLPFADRSFDAVLNVESSHCYDSIDTFASELKRVLRPGGVVLLTDLRPAQDMPELGRTF
>spirangien_2
HLVDTLFAKLPERGRVLDVAFGKGVSTKRLEERYGAENVAGINIDADQVQIARERGVTCDLRVMDAAKPDFPSESFDAILCIESAFHFQSRAQFLAEAHRMLRPSGVLVM
>lymphostin_1
ADLLELKPGERVLDLGCGRGACLFPIAAQVGTEGFVLGIDQAPGMVEACGADLEARGLADRAQVRLGDVQSFTVDRPFDAISAGMVLFLLPAPQQALAAAAAALRSGGRLVATTFPTENGRLAAGWESAEILA
>BE_54017_1
LVEQLPAGSRALDAGCGSGNNCGMLAERYDDVVGVDVSRKMLDIAATKRTRVPVRYECRDAVDLTPERDGRFDLVMSVNAVFHMGPADEVLPVLRALVAPGGRLVVV
>microcystin_2_1
KTVELLLSSYPPSASLRILEIGAGTGATTQQVLKACNSRQITYTFTDVSPFFLEKARDNLAEFSELEYKVLDIEKDPKLQGFCCHSYDLIIAANVLHSTANLQEETLPHIQSLLRPGGHLLLL
>microcystin_2_2
AQKPKKVLEIGCGTGLILFQVAPHCQCYWGTDISSVALDHIQRINQEGPKLEQVRLLHSTADKFEGLESEGFDTIILNSVVQYFPHIDYLLRVLEGAIKVLTPGGCIFLGDVRNLQLMEA
>calicheamicin_1
WLLRAAGLRPGHRVLDVGCGTGEPSVSAGRLVAPTGRVLGIDLSPEMVDRARRCAAGLGHPIDFAESDVEALDLPAHSFDAVLS
>GE2270_2_1
LALVHRMVTYRGGRALDLCAGPGVQALTAALRSEHVTAVEINPVAAALCRTNIAMNGLSDRMEVRLGSLYDVVRGEVFDDIVSNPPLLPVPEDVQFAFVGDGGRDGFDISWTILDGLPEHLSDRGACRIVG
>pederin_1
ALLDFIPEKSGRILDAACGMGASTRHLLEYYPADNIWAINISEKQIEATRRNVPGCHAQVMNAVDLSFEEGFFDNILCIEAAFHFETRQKFLEEARRILRPGGRLVL
>rebeccamycin_2_1
ATDRLTDEMIALLDVRSGDRVLDVGCGIGKPAVRLATARDVRVTGISISRPQVNQANARATAAGLANRVTFSYADAMDLPFEDASFDAVWALESLHH
>rebeccamycin_3_1
ATDRLTDEMIALLDVRSGDRVLDVGCGIGKPAVRLATARDVRVTGISISRPQVNQANARATAAGLANRVTFSYADAMDLPFEDASFDAVWALESLHH
>melithiazol_2_1
ILYRGVDFSTRTRVLDIGCGHAADLVDLARAHPHLELHGCNISPDQIEVGRQRIRALGLDGRVLLHYQDSSRDQFPSTYDLVIAYQVIHHIRAKSDLFANISRSMKPGGLLIM
>myxovirescin_1
SGREVLEVGCGRGGGSEYLMTRLKPRSLTAVDLSDVAIARCKENYRLDGLSFQVGNACALPFEDRRFDVVVNIESSHCYPSQLTFFEEVKRVLKPGGAFCFADITESAEHTARINEEFK
>collismycin_1
STVVDVGGGDGTLLAAFLDRYPHLTGTVLETEAGAARARETIAGSGLTDRCRAVAGDFFAEVPKGADLYLIKNVVLNWDDERAWTILRRVRDAMPDHGKLLIAEPVLP
>collismycin_2
RALGARRVLEIGCGTGLLAMRLAPDAERYVGSDLSAVAIRRLRAQMDAAGLDHTELVHAPADDLDAVPGGTFDVVVLNSIVQYLPSAQYLREVIERAAARLAPGGHLFVGD
>marineosin_1
RPVRLLEVGCGSGTYVRHAARLTPRLSALAIDMQKNVADQAASNMAEWGLTDRVETRQGDLRTLDLEPQFDLVTMHNNIYYFPQDDRVETLRRARRLLAPGGKLLLTTS
>grisemycin_1
AGRTVLDLGAGTGVSSFALADAGAQVVAVDASRPSLDLLESRRGERKVDTVEADFRDLRLDSAFDVVTMSKNTFFLAQSHDEKIELLRAIGRHLKPGGAVFL
>prodigiosin_1
RLLEIGCGSGVHVRHAASLNPHLTALAVDLQAEVAKQCAENIEDWGLADRVEVTQGDLRTLDLEPQFDLVTMHNNIYYFAEDERVEALRRARELLTPGGRLLVTTACQGGH
>rakicidin_1
ILQDSPRSVLEVGCGTGLILYRVAPHVRRYWGTDISAVALDRLRADVPTRGLSGVELFGCAADELDTLPDQLFDVIVLNSVAQYFADEDYLLRVIEGALPRLAPGGSLFLGDIRSLPLLETF
>congocidine_1
TQRLVDICEAPAGGVVADVGCGSGLATELLLARAAHVGAVIGIDPSEHELAIARTRLRDPKVRFVRGRAQDVESLTGPVDVAVLSNVMHQIPAAERGAVVEGCHRLLAPGGR
>glivocarcin_1
RGHVLDLGCGLGDNALYLASRGLRVSAVDISEVAVQCGRDKARDHGVSVDFQVTDAFRLAESGVRYDAVLDSAFFHT
>thiocillin_1
YMARKVAASDLDVLLDIGCGSGLTAVQISKKENCKIVGINISEKQLAIGKKLISKEKINSRVKLMNMDAH
>resistomcycin_1
AAAVPLAGVRRVVDLGCGSGDYSIALASHHPELRVTALDYPAVTDLARANVREAGLEDRIEVRPADIMADAWPETDAVLLSHVLDGYGPERAAHLVKRIHAHLPDGGRLLV
>resistomcycin_2
EALGLRRAGRVLDLACGGGEWGIALAAADPRAEVTAHDDPVLLGSARARAAEFGVADRFRFVSADFAAPPFADAGFDTVVLAHAGRFAGPTATARLVRECARQLRPGGTLLVA
>microsclerodermins_1
ARVLEVGCGTGMILLRVAPHAQRYVGVDFSAVVLEQLAAKVAERGLANVRLERGAATELDRLGERGFDAIVLNSVIQYFPGLDYLALVIERALELLDDGGSIFL
>caprazamycin_1
ALLAEVYPVHTGRLLDIGCGTGTYSLLIAELGFDVHGVDTSERMVERARAKALERGAGPGVSFSTLPAQDISGQYDAVFS
>aclacinomycin_1
PAAGARVLDVGCGRGACVFPAAERVGPEGRVVGIDVAEAMIEEATKEAALRDAAMVELRVMDGEHPDFAPHSFDVVL
>plantazolicin_1
YSVLDIGCGQGQVIQYLNSRFQKIELTGIDSSAQAISSAKKLGINASFICSNAENIMQYVSKKQDII
>elloramycin_1
VAFDIGTGTGVLAAVLARRGVPEVVATDLNPRALACARENLDRLGLAERVTVMEADLFPPRRRASLVVCNPPWLPAKPTSELESAVYDPGGRMLRAFLERLPRHLEPGGEAWLVLS
>cystargolide_1
YGSAVSVVAMSVPATARILDLGAGTGLLGAALRERLPDAELLLQDRSQAMLEQARQRFADDDQVAIRVADHLDELPAGPFDAVVSALSIHHLEHQDKQDLFTRIRKILRPGGIFVNVEQVLAPTSELE
>lankamycin_1
TDQLTDQLIARLAPAPGQRILDVGCGVGEPAFRLARTADVEVVGVSISAYQVGRAGERARDFGLADRVSFRHADAAELPFPDASF
>novobiocin_1
GQTVVDLCCGSGELEVILSSRFPSLNLVGVDLSEDMVRIAREYAAEQGKALEFRHGDAQLLAGMEDLAGKADLVVSRNAFHRLT
>FD_891_1
TEQLYERLDVSAGHKVLDVGCGVGKPAAWLARKTGATVKGANVSRNQLEVARDRVRSEGLEDRVSFDLADAMHLPYADDSFDRIWAIESMIHMPDRDQVMREMARVLRPGGRLAI
>FD_594_1
XRALDLGCGTGANAVFLAQNGFDVVGVDFTEYALQRARERAREAAVEDHCRFVNADLSSP
>doxorubicin_1
PVTGERVLDIGCGRGACLFPAAEKVGPQGRVHGIDIAPGMIEEARKEAAERGLRNIALDVMDAETPELPARSFDLVM
>viridisamide_1
QPGNYIFDAGCGAGIPAIHIAQSFPGTRIEGLTISEVEAAEAQTRIAQTNLVDRVRVQVGDFHSPPFPNEVFDVVFFNDSIKYSNQLPQVLAEVKRVLRPGGTLYI
>A201A_2_1
REWRLHRGVFPGTITAATEVMASVLPYPRGGSFLEIGCGSGVIAVTAALSGAARVTAVDINDRAVANTAENARFHGVEDKVTVLHGDLFEAVPPTDRFDVIFWNVPWTWVPEDFSMSTELHSAVFDPDYRAQARFIAEAGAHLADGGRTLIGTADLADQRLLERLAEERGLRLELVRRVRRIEV
>plantazolicin_2_1
VSILDIGCGQGQMLEYISKQLPLADLTGIDSSEEAIHCANKLNIKANFIC
>gephyronic_acid_1
PGQRVLDVGCGFGGTLASINRRLRGMSLVGVNVDERQLERAAEHVKPTNDNEISWVRADACDLPFDDGSFDVIMVVEAICHFRSRARFFAEARRLLSPGGVLVV
>muraymycin_1
KSQLLHDWIDRYTPGKRVLDLFCANGAFSIRAALAGAKEVTGVDAEPSRIAVANLLAKSLSDHVDTTFDFSVQDVHDVLDRDETYDVVMC
>BE_43547A1_2_1
WVDRTAELVLERAPRSVLDVGCGTGLILHAVAPHCRRYWGTDFSTVALDRLRRSARYPGDVQLHECAADQLDRLPDQLFDVVLLNSVVQYFPDGEYLARVIEGALRRLAPGGAVVIGDVRSLPLLEAFHTS
>myxothiazol_1
SSVRKVLDFGCGYASDLISLGKKHPHLTLHGYTISAEQAAIDEERVRARGLQDRIRVFARDSAKDAFPDRYDLIF
>nogalamycin_2_1
GMDRASQRLTEMMTERIEVGPGQRVLDIGCGTGAPAVQLARATGAEVVGITISPEQVRLATAHAEREGVAERVTFRCADASAELPFPADSFDAVWFFESIFHLPDRLTALRRAAEVLRPGGRLAL
>apoptolidin_1
RDKRVLEVGCGIGAGLNFLSRVTGAAQLSGVDISKAAIARANGRYSRGEQLTYTVGDAENLPFEDGAFDVVVNVESSHSYPSLGRFFDEVARVLKPGGYLSLVD
>taxlllaid_1
SATVHAGLGGARSTTTVDMSRTYLEWAEKNLQANGLSGRQHRLIQADCLGWLAQSREQFDLIFIDPPTFSNSKRMEDSFDVQRDHITLMKQLKCLLRRGGTLMFSNNKR
>SW_163_1
VKGDVFDPGCGTGETSLYLASKGHTVTGVDFSATAIATARRKAEERGLDVTFEVADILEDGGKSGLYDTVI
>cosmomycin_d_1
LVERADPQPGQRVLDVGCGRGASLFVAAERVGPSGHVLGIDIAPAMVEEARRQAGALGARHVEVRVMDGEHPDLPPASFDVV
>cosmomycin_d_2
RHVLDVGGGNGGLLAAIALRAPHVRGTLVELAGPAERARRRFEDAGVDDRVTVAEGDFFKPLPVTADLVLLSFVLLNWSDEDALTILRRCVQALEPGGRILVLD
>micropeptin_k139_1
LLEFIPNKQGTILDVGCGLGATTHYLLKYYPLTAIVGINISPTQIARSLLNFPEGKFLLMDAVEMDFADHSFEQIICVEAAFYFNTRQQFLREAWRVLKPGGTLIL
>puwainaphycins_1
HRVLEIGCGTGLLLFRIAQQCQHYYGTDISHHALQYVEQQMSKLGGDWSQVQLAQGSADQFQEFETASFDAVILNSVVQYFPSIDYLIRVVATAVAANTPGGFIFIGDVRHLPLLEAFHT
>triostin_a_1
ISGAVLDAGCGTGEDILHLAGKGYAVTGLDLSSEAVAIARRKAEERGLDATFAVANALELAGYEGRFDTVV
>myxochromide_a_3_1
KPRRVLEIGCGTGLLLTRIAPSTEAYWATDVSGVVVNMLRSNTAKSAGLEHAKLFHCAADQLDGIDFGDMRFDAVMLNSVVQYFPSAEYLAQALEKASQRLDTGGVIFV
>carotenoid_2_1
GTRVLDLGCGTGASTAALAAVLPGAEITAVDASAGMLERAAAKPWPDRVTFVHAPAERLTEAGVEGPFDAVFAAYLFRNAAAPDSVLTAVHDVLAPQGRLA
>BE_7585A_1
NYDPGTRGMITGLGIRPDWRCLDLGAGLGSMSRWLAGQVPRGSVLALDRDTTALAGAAA
>flexirubin_1
QLLPRQGRILDIGCGYGFMSYMLHWLSAEREIKGLDYDEEKITTAQHCYLRNEHVSFEHADITNYTFEKYDAFVISDVLHYLQPGEQEKVLSACISQLNEGGVIIV
>apramycin_1
RAVEIGCGAAAAICTLAKELTGEFVGTDVVPEALELAEENATRHRAPVRFVVSDLFDALDGRFDVIYANLPRHHPSTPMPEARWEPSVALYDDSAEPFGLLRRFFAEVPDRLTERGRLYL
>monensin_1
TDEMIRRLDPAPGDRVLDIGCGNGTPAMQLARARDVEVVGISVSARQVERGNRRAREAGLADRVRFEQVDAMNLPFDDGSFD
>cereulide_1
ACFDPCCGEGTILRSFADAVKQVGIQLDTYGVELDANRYNKAKEQLDVVIRSSFESMMISHDYFPLIFLNPPYNTELRTEKKKSEKMEFNFLKRAHHYLQDGGIMVYVIP
>pactamycin_2_1
DVRTALDLGCGTGILGLSAARNGADVVSVDVNPECTAAATVNAHINGLGERLTAVEGDIMSLDLDRRFDLVISNPPCLPL
>A_90289_1
LLAEIYPVHRGRLLDIGCGTGTYSLLMGELGFDVHGVDTSQRMIERARAKALGCGAGAAVTFSTLAAQDISGRYDAVFS
>ravidomycin_1
ITGDVLDVGCGLGDNAAFLASQGHRVTAVDVSQIAVDEASARASAKGVEVEFAVTDATRLTGFDGRFDTVVDSACYHS
>ravidomycin_2
VSGVFNDAMTEASRQLIAPVVDAFDFGDIGTLVDVAGGRGALLSAVLKANPKTRGVLYDQPEVVSEARQNFARSGVADRVEIIGGDFFSSVPPAGDAYLLSNVLHDWDDESSLKILANCRAALGDGGRVLLVE
>legonaridin_1
AVKGLLALHPAPDAGTIELGVGTGRIAIPLSESVGHVTGVDSSPEMLDAMRVKLKDRGDVTPVHGDIRTYTSDSRYGLVYCVCATLSLLHTREDQQRAVRCAADLLAPGGRLVIET
>BE_43547A1_1
DRTAELVLERAPRGVLDVGCGTGLILHAVAPHCQRYWGTDFSTVALDRLRHSARYPGDVQLHECAADQLDRLPDQLFDVVLLNSVVQYFPDGEYLARVIEGALRRLAPGGAVVIGDVRSLPLLEAFHTSVE
>staurosporine_1
EATDRLTDLVAERLALRPDRQLLDVGCGIGVPALRIAGAHDVRVTGITVSQQQVTEAAARAVESDAGGRVSFRLADAMD
>staurosporine_2
AMDRLTDVFIERLNAYATSHVLDLGCGVGGPGLRVVARTGARVTGISISEEQIRTANRLAAEAGVADRAVFQHGDAMKLPFADASFDAVMALESICHMPDRQQVFTEVSRVLRPGGRI
>2_methylisoborneol_3_1
AEFLLDHLGGVEPEHRIMDAGCGRGGSSFMAHERFGCSVEGVSLSRKQVDFANAQARERGVADKVAFHQLNMLDTGFDTASMRAIWNNESTMYVDLHDLFAEHSRLLARGGR
>tambromycin_1
RGDLPLIDLGCGNGRYSRELAPHYPRVVGVDVSASAIDHAKREAEGVANVDYLAIDMTDAEQAAVLGEGPYNIFVRGVFHVLDTEARARLAAVADRLLGDEGTLIVH
>tubulysin_2_1
PRSILEIGCGTGLMLFALLPHCERYVGTDFSQSALDYVGQHLPAEARSRVELSCRAADDWSGMTPRSFDAVVINS
>crocacin_1
ARRVLFSAVDIEAIGSVFDFGCGHASDLLQLAQEHPHLELDGYTISPGQAALAARKLRATGLEARVRVFNRDSAKNPFPRHYDLILGIEVAGLIQDKEALFSNIGRHLNPGGFL
>crocacin_2
PDGAKIVDMGCGTGNFALAIARSCPRATISAYDNNERMLEVLRYKAERAGVPIQARAADLRTRPEALESVDAISYVHCLYVLQKPGALEALAQARAMLKPGGYLVV
>echinomycin_1
AGLIQGAVLDAGCGTGEDALHLAGLGYAVTGLDLSPTAISVARDKADARGLGAVFEVADALDLTGWEERFDTVI
>furaquinocin_a_1
FDVPAGARVLDVRGGNGLGAIMTCQTKASPGLRVTTLDRPALEAECLRNCEAHGVAEQCSCVGGEVLDALPGGFDVLLLKHFVDMYDKDDVLTMFRNAHRALEPGGQIVVL
>pactamycin_1
DVRTALDLGCGTGILGLSAARNGADVVSVDVNPECTAAATVNAHINGLGERLTAVEGDIMSLDLDRRFDLVISNPPCLPL
>belactosin_1
ATVPTAPRVLDLGAGTGLLSAAILRELPDSEVVLVDRSELMLTQARGRFASQDGVTVQTGDLTDPLPEGGFDAVVSGLAIHHLSHTGKRDLFRRIREALRPGGVFVNVEQVQGPLPHLESLYDSQHELHVI
>belactosin_2
SALLLPHADPARVIVDLGCGNGTQTRYLATRFARAIGVDLSHAAVAHARRAAGDAPVEFEQLDLTDSDAVKALHDRLGD
>haliamide_1
FLDAVAAAVKDGDIVVDLGTGTGVLAMAAARAGARRVHAIEANEIIRGAKAVAQANGLESKIVFDHGEAARITLPEPVDVLVS
>sodorifen_1
AMHRILDIGCGWGYILKHLAERYPECQRLDGVNVSAQQLNYCARSHAEQGLSGRINLFLCN
>onnamide_1
LMAMIPKKSGRILDAGCGTGGATRRLLESYPPENVWAINISAKQIETTKQNVKGCHAIVMNAVDMTFEDNFFDTVLSIEAAMHFETRRKFLEESFRVLKQDGCLVL
>onnamide_2
MLLEMIPEKTGRILDVACGMGASTRRLAELYSPENVWAINISEKQIESTRENAKGCHVQVMSAVEMTFDNDFFDTIMCIEAAFHFETRRKFFDDSLRVLKQGGRLVLSDT
>onnamide_3
ADRLTQIMIDKTTIEKGQKFCDLGCGWGGPAVALAKAKGCYIDGITCSGQQQQNAVKKAQELGMDDLLNFIHGDALNMPCKDQTYD
>polytheonamides_1
SHLLLYYMPVEAIRPADHILDLCTGTGVIGLGLSRFSEHVVSTDIAPPALRLAHMNRALNNAEGRVSIRAENLQETLASDECFDLIACNPPYVAAPPELPTPLYAQGPDRDGLGYLRLLMERAPEKLNPGGQAMFVV
